Skip to main content

News

News
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
News
09/17/2026
Rebecca Amrick
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has...
09/17/2026
Pharmacy Learning Network
News
09/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug...
09/17/2026
Pharmacy Learning Network
PharmLaw
09/16/2026
Hannah Musick
Dompé U.S. has agreed to pay $32 million to resolve allegations involving Medicare copay assistance for Oxervate, highlighting Anti-Kickback Statute compliance risks associated with manufacturer-funded patient assistance programs and the...
Dompé U.S. has agreed to pay $32 million to resolve allegations involving Medicare copay assistance for Oxervate, highlighting Anti-Kickback Statute compliance risks associated with manufacturer-funded patient assistance programs and the...
Dompé U.S. has agreed to pay $32...
09/16/2026
Pharmacy Learning Network
News
09/10/2026
Rebecca Amrick
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate)...
09/10/2026
Pharmacy Learning Network
News
09/10/2026
Rebecca Amrick
A voluntary Class II recall has been issued for trazodone hydrochloride tablets after the firm discovered foreign tablets in the product, a discrepancy that affects 175 392 bottles.
A voluntary Class II recall has been issued for trazodone hydrochloride tablets after the firm discovered foreign tablets in the product, a discrepancy that affects 175 392 bottles.
A voluntary Class II recall has...
09/10/2026
Pharmacy Learning Network
News
09/10/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for famotidine injection due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug Administration (FDA) has issued a Class II recall for famotidine injection due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug...
09/10/2026
Pharmacy Learning Network
PharmLaw
09/09/2026
Hannah Musick
Florida has sued Express Scripts and Prime Therapeutics over allegations that the pharmacy benefit managers (PBMs) unlawfully coordinated pharmacy reimbursement rates, raising new antitrust and compliance questions surrounding PBM contracting...
Florida has sued Express Scripts and Prime Therapeutics over allegations that the pharmacy benefit managers (PBMs) unlawfully coordinated pharmacy reimbursement rates, raising new antitrust and compliance questions surrounding PBM contracting...
Florida has sued Express Scripts...
09/09/2026
Pharmacy Learning Network
News
09/03/2026
Rebecca Amrick
Acthar Gel (repository corticotropin) injection is under a voluntary Class II recall due to the presence of particulate matter, affecting 12 367 vials.
Acthar Gel (repository corticotropin) injection is under a voluntary Class II recall due to the presence of particulate matter, affecting 12 367 vials.
Acthar Gel (repository...
09/03/2026
Pharmacy Learning Network
News
09/03/2026
Rebecca Amrick
A voluntary Class II recall has been issued for clobetasol propionate cream after the product failed to meet content uniformity specifications.
A voluntary Class II recall has been issued for clobetasol propionate cream after the product failed to meet content uniformity specifications.
A voluntary Class II recall has...
09/03/2026
Pharmacy Learning Network